Efficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping review

Efficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping review

IntroductionThis scoping review explores the effectiveness of IL-1 pathway inhibitors in managing PSTPIP1-associated inflammatory diseases (PAID). These diseases are marked by abnormal IL-1 pathway activation due to genetic mutations.MethodsOur methodology adhered to a pre-published protocol and inv...

Full description

Bibliographic Details
Main Authors: Juan Luis Sanz-Cabanillas, Francisco Gómez-García, Pedro Jesús Gómez-Arias, Ana Montilla-López, Jesús Gay-Mimbrera, Juan Ruano, Beatriz Isla-Tejera, Esmeralda Parra-Peralbo
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
autoinflammatory diseases
PSTPIP1 gene mutations
PAID
interleukin 1 pathway
IL-1 inhibitors
anakinra
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1339337/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1339337/full

Similar Items